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A B S T R A C T
Hyperuricemia may have an important role in metabolic syndrome, cardiovascular diseases and stroke. Elevated se-
rum uric acid concentration has been shown to be the strong predictor of cardiovascular mortality in several recently
published studies. Our aim was to determine the prevalence of hyperuricemia in general Croatian population and to in-
vestigate the association of serum uric acid with glucose and lipids. This was a retrospective cross-sectional study on
6,476 consecutive adults. Prevalence of hyperuricemia was 13.9% in general population and it was significantly higher
in males, than in females (26% vs. 6%; p<0.001). Median uric acid concentration was higher in males than in females
(343 vs. 238 mmol/L; p<0.001). Age, glucose and lipid parameters did not correlate with uric acid. In hyperuricemic sub-
jects, increased concentrations of glucose (33.1% vs. 13.1%; p<0.001), triglycerides (46.9% vs. 17.6%; p<0.001), total cho-
lesterol (69.6% vs. 51.9%; p<0.001), LDL-cholesterol (64.5% vs. 46.4%; p<0.001) and decreased concentration of HDL-
-cholesterol (24.3% vs. 13.0%; p<0.001) were more prevalent than in subjects with normal serum concentrations of uric
acid. Hyperuricemia is highly prevalent in Croatian general population and it aggregates with hyperglycemia and dysli-
pidemia.
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Introduction
The concentration of serum uric acid is controlled by
many factors, including genetics, insulin resistance, re-
nal function, obesity, diet and alcohol consumption1,2.
Elevation of the serum uric acid level (i.e. hyperuri-
cemia) more frequently occurs in males and overweight
persons and its prevalence varies in different popula-
tions3. It has been reported that hyperuricemia may
have an important role in several pathological condi-
tions such as metabolic syndrome, cardiovascular dis-
eases (CVD), chronic kidney disease, stroke, maternal
complications in pre-eclampsia4–7. Elevated serum uric
acid has been shown to be the strong predictor of cardio-
vascular mortality in several recently published stu-
dies8–10, whereas some other publications were not able
to confirm these findings11.
Hyperuricemia has also been associated with certain
metabolic abnormalities, such as impaired glucose me-
tabolism and dyslipidemia and several investigators
have studied this association12,13. However, these associ-
ations are not yet fully understood and results are still
inconsistent.
We have, therefore, undertaken this study with the
aim to: (i) determine the prevalence of hyperuricemia in
general Croatian population and (ii) investigate the asso-




This was a retrospective cross-sectional study on pa-
tient laboratory results retrieved from the laboratory in-
formation system (LIS). The study included laboratory
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results for 6,476 consecutive adults referred to medical
biochemistry laboratory of Policlinic Bonifarm for rou-
tine blood testing, mainly as a part of the routine peri-
odic health check-up between June 2007 and February
2009.
Policlinic Bonifarm is policlinic specialized in phar-
macology and toxicology and medical biochemistry labo-
ratory. Total number of samples admitted to the labora-
tory is 11,000 per year and the total yearly number of
analyses is about 75,000.
Methods
Following data were retrieved from the LIS for every
individual: age, gender, concentration of glucose, triglyc-
erides, total cholesterol, HDL-cholesterol, LDL-choles-
terol and uric acid.
For all patients venous blood sampling was done in
the morning, after an overnight fast. All laboratory tests
were done immediately after sampling.
All biochemical parameters were measured by stan-
dard enzymatic methods on analyzer Cobas Integra 400
plus (Roche Diagnostics, Mannheim, Germany).
LDL-cholesterol was calculated using Friedwald equa-
tion. When triglyceride concentration was above 3 mmol/L,
LDL-cholesterol was measured by direct method on Co-
bas Integra 400 plus (Roche Diagnostics, Mannheim,
German).
Statistical analysis
Categorical data are presented as counts and percent-
ages. Normality was tested using Kolmogorov-Smirnov
test. All distributions were non-Gaussian. Median and
interquartile range (IQR) were used to describe the data.
Data were categorized into two subgroups: with (a) nor-
mal and (b) increased (decreased for HDL) concentra-
tions of measured parameters. Cut-off values used for
grouping were 5.5 mmol/L for glucose, 5.0 mmol/L for
cholesterol, 1.7 mmol/L for triglycerides, 3.0 mmol/L for
LDL cholesterol and 1.0 mmol/L and 1.2 mmol/L for
HDL cholesterol for males and females respectively. Tho-
se values were chosen according to the recommended
ATP III criteria14. Value for HDL in females was slightly
modified according to national recommended value (Cro-
atian Chamber of Medical Biochemists). As a cut-off
value used for categorizing subjects respective to the con-
centration of uric acid, we used the upper limit of refer-
ence interval (URL) (403 mmol/L for males and 337
mmol/L for females).
The c2-test was used for comparing categorical vari-
ables and Mann-Whitney rank sum test for assessing dif-
ferences between numerical variables. Spearman rank
correlation analysis was used to assess the association
between variables (uric acid, age, glucose, lipid parame-
ters). The level of statistical significance was set at 0.001,
due to the large sample size.
Statistical analysis was performed by using MedCalc
10.1.2.0 (Frank Schoonjans, Mariakerke, Belgium).
Results
The study included 6,476 patients. Patient demo-
graphic characteristics and biochemical parameters are
presented in Table 1.
Hyperuricemia prevalence was 13.9% in general pop-
ulation and it was significantly higher in males, than in
females (26% vs. 6%; p<0.001). Furthermore, median
uric acid concentration, although within the reference
interval, was higher in males than in females (343 vs. 238
mmol/L; p<0.001).
We have tested possible correlations of uric acid with
age, glucose and lipid parameters. As of our result, age,
glucose and lipid parameters did not correlate with uric
acid in studied population (data not shown). Correlation
was not present even when we analyzed the relationship
of uric acid with age, glucose and lipids within the uric
acid quartile subgroups (data not shown).
Study subjects with hyperuricemia were found to
have higher prevalence of increased concentrations of
glucose (33.1% vs. 13.1%; p<0.001), triglycerides (46.9%
vs. 17.6%; p<0.001), total cholesterol (69.6% vs. 51.9%;
p<0.001), LDL-cholesterol (64.5% vs. 46.4%; p<0.001)
and decreased value HDL-cholesterol (24.3% vs. 13.0%;
p<0.001) compared to subjects with serum uric acid lev-
els within the reference interval (Table 2).
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TABLE 1
PATIENT DEMOGRAPHIC CHARACTERISTICS AND BIOCHEMICAL PARAMETERS
Male, N=2,827 Female, N=3,598 p
Age, years* 43 (34–52) 41 (33–50) <0.001
Uric acid, mmol/L* 343 (300–391) 238 (204–276) <0.001
Hyperuricemia, N (%) 1.683 (26%) 389 (6%) <0.001
Glucose, mmol/L* 5.1 (4.8–5.5) 4.7 (4.5–5.1) <0.001
Cholesterol, mmol/L* 5.3 (4.6–6.1) 5.0 (4.4–5.8) <0.001
HDL-cholesterol, mmol/L* 1.3 (1.1–1.5) 1.7 (1.4–2.0) <0.001
LDL-cholesterol, mmol/L* 2.8 (2.3–3.5) 3.3 (2.6–3.9) <0.001
Triglycerides, mmol/L* 1.4 (0.9–2.0) 0.9 (0.7–1.3) <0.001
*Data are presented as median and interquartile range
Discussion
The prevalence of hyperuricemia in this study was
13.9% in general population and it was significantly
more prevalent in males, than in females. Age, glucose
and lipid parameters did not correlate with uric acid con-
centration in studied population. However, hyperurice-
mic subjects more often had increased concentrations of
glucose, triglycerides, total cholesterol, LDL-cholesterol.
HDL-cholesterol concentrations were more often decrea-
sed in our subjects with elevated uric acid concentration.
Eventhough the prevalence of hyperuricemia and its
association with various biochemical parameters has been
studied by many authors, the results are controversial
and not yet conclusive. The overall prevalence of hyper-
uricemia in one recently published study on 132 subjects
from western Turkey was 12.1%3. The cut-off values for
uric acid in this study were >420 mmol/L for males and
>360 mmol/L for females, what was comparable to cut-off
values used in our study. Males had significantly higher
uric acid concentrations than females (330±80 vs. 260±70
mmol/L, respectively; p=0.05). This gender dependent
difference in uric acid concentrations may probably be
explained by gonadal hormones15.
Lippi et al.12 have investigated the association be-
tween uric acid, fasting plasma glucose and triglycerides
in the general population. The overall prevalence of
hyperuricemia in 10,181 randomly selected individuals
was 3.8%. It should be noted that cut-off values for uric
acid were much higher than the ones used in our study
(uric acid cut-off values were 506 mmol/L and 416
mmol/L, for males and females, respectively). This might
explain the observed large difference between the preva-
lence in our and Italian population. The major finding of
the study by Lippi et al. was that hypertriglyceridemic
(triglycerides >1.7 mmol/L) and hyperglycemic (fasting
plasma glucose >6.1 mmol/L) adults had increased prev-
alence of elevated serum uric acid concentrations, com-
pared to subjects having normal lipid and glucose con-
centrations (11% vs. 3%, respectively; p=0.018). The
authors conclude that this association raises the possibility
of a potential pathogenic overlap between these states.
Hjortnaes et al.16 have investigated the association be-
tween serum uric acid and components of metabolic syn-
drome in patients with manifest vascular disease. They
observed higher average concentrations of serum uric
acid in patients with, than in patients without metabolic
syndrome (360±80 mmol/L vs. 329±90 mmol/L). Further-
more, their observation was that the patients who had
more components of metabolic syndrome present, had
also higher concentration of serum uric acid.
Rathmann17 and his colleagues have published the re-
sults of the Cardia study with the 10-year follow-up on
1,249 male and 1,362 female young subjects. During the
follow-up, they observed the significant increase of the
mean serum uric acid concentration (p<0.01). They also
observed a significant independent association of body
mass index (BMI) and triglycerides with serum uric acid.
In the study published by Liou et al.18, uric acid aggre-
gated with BMI, waist circumference (WC), glucose, log
value of triglycerides, and HDL cholesterol. However,
their conclusion was that metabolic syndrome is not as-
sociated with hyperuricemia.
In one recently published cross-sectional study on
2,085 Taiwanese men and 1,557 women19, hyperuricemia
was significantly associated with increased risk for hy-
pertriglyceridemia, low high-density lipoprotein choles-
terol level, and high blood pressure in men and women.
However, contrary to our results, the uric acid levels
were inversely associated with hyperglycemia in Taiwan-
ese men. In one other similar study on 470 subjects, who
were also from Taiwan, serum uric acid was significantly
related to risk factors of metabolic syndrome, with the
exception of blood glucose which did not correlate with
uric acid20. It may be that there are some racial and eth-
nic differences in metabolic interactions of the compo-
nents of lipid and glucose metabolism. Furthermore, the
observed difference in the association between glucose
and uric acid may also be at least partially due to large
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TABLE 2
PREVALENCE OF SUBJECTS WITH HYPERGLYCEMIA AND DYSLIPIDEMIA RESPECTIVE TO THE URIC ACID CONCENTRATION







746 (13.1%) 261 (33.1%) <0.001
Cholesterol >5.0 mmol/L
N=3,500 (54.0%)
2,947 (51.9%) 553 (69.6%) <0.001
Triglycerides >1.7 mmol/L
N=1,374 (21.2%)
1,001 (17.6%) 373 (46.9%) <0.001
LDL cholesterol >3.0 mmol/L
N=3,151 (48.7%)
2,638 (46.4%) 513 (64.5%) <0.001
HDL cholesterol 1.0 (M) mmol/L
HDL cholesterol 1.2 (F) mmol/L
N=929 (14.3%)
736 (13.0%) 193 (24.3%) <0.001
URL – upper limit of reference interval
differences in diet and lifestyle between Western civiliza-
tions and Asian subjects21.
So, although not confirmed by all, uric acid was mo-
stly found to aggregate with disturbed metabolism of glu-
cose and lipids. Uric acid is known to correlate with insu-
lin resistance. The mechanism of this phenomenon is not
fully understood. It has been postulated that insulin
probably decreases the clearance of uric acid in the renal
proximal tubule, resulting in a subsequent increase in se-
rum uric acid levels in healthy individuals and asymp-
tomatic hyperuricemic subjects22.
As such, the measurement of uric acid might be advis-
able to those at increased risk of CVD23. However, there
is a continuing debate about the relevance of the in-
creased serum uric acid concentration and its role as an
independent cardiovascular risk factor. The predictive
value of uric acid concentration for cerebrovascular and
cardiovascular mortality has been studied in several lar-
ge prospective studies. In the prospective cohort study on
1,423 middle-aged Finnish men initially without CVD,
published by Niskanen et al., serum uric acid was a
strong predictor of cardiovascular mortality, independ-
ent of variables commonly associated with gout or the
metabolic syndrome8. Elevated concentrations of uric
acid were also associated with increased mortality in one
Austrian cohort of 83,683 subjects10. However, one pro-
spective cohort study on 22,698 Korean men, aged 30 to
77 years, with a 9-year of follow-up found that elevated
serum uric acid was not an independent risk of cardio-
vascular mortality11. It is therefore clear that we still
need some well designed prospective trials and moni-
tored therapeutic interventions to further improve our
understanding of the risk factors for metabolic syndrome
and cardiovascular mortality24.
Despite of the very intense research on this field,
there is still much controversy on the role and signifi-
cance of uric acid and its relation to some biological pa-
rameters. Such controversy may be due to the different
cut-off used to define hyperuricemia, small sized studies
and some ethnical differences, comorbidity and other dif-
ferences in studied populations.
The present study has some limitations. The study
population of outpatient adults from laboratory may not
be completely representative sample of general popula-
tion. Anthropometric measures, like BMI and some other
important data on the comorbidity (like hypertension,
cardiovascular disease, etc.), therapy, diet and other envi-
ronmental factors would be very useful to further ex-
plore these complex associations. Unfortunately, none of
the additional clinical information was available on this
large cohort of outpatients.
Conclusion
Hyperuricemia is highly prevalent in Croatian gen-
eral population and it aggregates with hyperglycemia
and dyslipidemia. Males are more often hyperuricemic
than females.
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POVEZANOST MOKRA]NE KISELINE S GLUKOZOM I LIPIDIMA U OP]OJ POPULACIJI:
PRESJE^NO ISTRA@IVANJE U HRVATSKOJ
S A @ E T A K
Hiperuricemija mo`e imati zna~ajnu ulogu u metaboli~kom sindromu, kardiovaskularnim bolestima i mo`danom
udaru. Novija istra`ivanja su pokazala da koncentracija mokra}ne kiseline u serumu mo`e biti sna`an prediktor kar-
diovaskularne smrtnosti. Cilj ovog istra`ivanja bio je utvrditi prevalenciju hiperuricemije u op}oj populaciji u Hrvatskoj
i ispitati povezanost koncentracije mokra}ne kiseline s koncentracijama glukoze i lipida. Ovo retrospektivno presje~no
istra`ivanje provedeno je na 6,476 uzastopnih odraslih ispitanika. Prevalencija hiperuricemije je bila 13,9% u op}oj
populaciji. Hiperuricemija je bila u~estalija u mu{karaca, nego u `ena (26% prema 6%; p<0,001), a medijan koncen-
tracije mokra}ne kiseline je bio vi{i u mu{karaca nego u `ena (343 prema 238 mmol/L; p<0,001). Dob, koncentracija
glukoze i lipidnih parametara nisu bili povezani s koncentracijommokra}ne kiseline. Ispitanici s hiperuricemijom imali
su povi{enu koncentraciju glukoze (16,5% prema 6,8%; p<0,001), triglicerida (46,9% prema 17,6%; p<0,001), ukupnog
kolesterola (69,6% prema 51,9%; p<0,001), LDL-kolesterola (64,5% prema 46,4%; p<0,001) i sni`enu koncentraciju
HDL-kolesterola (24,3% prema 13,0%; p<0,001) ~e{}e nego ispitanici s normalnom koncentracijom mokra}ne kiseline
u serumu. Hiperuricemija ima visoku prevalenciju i povezana je s hiperglikemijom i dislipidemijom u op}oj populaciji u
Hrvatskoj.
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